169 related articles for article (PubMed ID: 20570056)
1. Entry of hepatitis B virus: mechanism and new therapeutic target.
Xie Y; Zhai J; Deng Q; Tiollais P; Wang Y; Zhao M
Pathol Biol (Paris); 2010 Aug; 58(4):301-7. PubMed ID: 20570056
[TBL] [Abstract][Full Text] [Related]
2. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
Leistner CM; Gruen-Bernhard S; Glebe D
Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
[TBL] [Abstract][Full Text] [Related]
3. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
4. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P; Cannie I; Urban S
J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
[TBL] [Abstract][Full Text] [Related]
5. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus.
Köck J; Nassal M; MacNelly S; Baumert TF; Blum HE; von Weizsäcker F
J Virol; 2001 Jun; 75(11):5084-9. PubMed ID: 11333889
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection is dependent on cholesterol in the viral envelope.
Bremer CM; Bung C; Kott N; Hardt M; Glebe D
Cell Microbiol; 2009 Feb; 11(2):249-60. PubMed ID: 19016777
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.
Baumert TF; Yang C; Schürmann P; Köck J; Ziegler C; Grüllich C; Nassal M; Liang TJ; Blum HE; von Weizsäcker F
Hepatology; 2005 Feb; 41(2):247-56. PubMed ID: 15660384
[TBL] [Abstract][Full Text] [Related]
12. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
[TBL] [Abstract][Full Text] [Related]
13. Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide.
Ye X; Zhou M; He Y; Wan Y; Bai W; Tao S; Ren Y; Zhang X; Xu J; Liu J; Zhang J; Hu K; Xie Y
Sci Rep; 2016 Jul; 6():29391. PubMed ID: 27384014
[TBL] [Abstract][Full Text] [Related]
14. Attachment sites and neutralising epitopes of hepatitis B virus.
Glebe D
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):3-21. PubMed ID: 16554703
[TBL] [Abstract][Full Text] [Related]
15. Small animal model systems for studying hepatitis B virus replication and pathogenesis.
Dandri M; Lutgehetmann M; Volz T; Petersen J
Semin Liver Dis; 2006 May; 26(2):181-91. PubMed ID: 16673296
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.
Walter E; Keist R; Niederöst B; Pult I; Blum HE
Hepatology; 1996 Jul; 24(1):1-5. PubMed ID: 8707245
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.
Schulze A; Mills K; Weiss TS; Urban S
Hepatology; 2012 Feb; 55(2):373-83. PubMed ID: 21953491
[TBL] [Abstract][Full Text] [Related]
18. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.
Meier A; Mehrle S; Weiss TS; Mier W; Urban S
Hepatology; 2013 Jul; 58(1):31-42. PubMed ID: 23213046
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
[TBL] [Abstract][Full Text] [Related]
20. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model.
Sureau C
Methods Mol Biol; 2010; 640():463-73. PubMed ID: 20645068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
